Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
J Clin Invest
    May 2025
  1. HUY TXN, Hop HT
    Mycobacterium tuberculosis hijacks the UBE2O pathway to regulate host iron homeostasis.
    J Clin Invest. 2025;135:e184095.
    >> Share

  2. NAZ F, Uddin MJ, Hagspiel N, Young MK, et al
    IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity.
    J Clin Invest. 2025;135:e184659.
    >> Share

    April 2025
  3. MISHRA B, Basu A, Shehadeh F, Felix L, et al
    Antimicrobial Peptide Developed with Machine Learning Sequence Optimization Targets Drug Resistant Staphylococcus aureus in Mice.
    J Clin Invest. 2025 Apr 22:e185430. doi: 10.1172/JCI185430.
    >> Share

  4. PELLEGRINI JM, Keriel A, Gorvel L, Hanniffy S, et al
    SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria.
    J Clin Invest. 2025;135:e182467.
    >> Share

  5. YOUNGQUIST BM, Mnguni AT, Pungan D, Lai RP, et al
    CRISPR-mediated detection of Pneumocystis transcripts in bronchoalveolar, oropharyngeal, and serum specimens for Pneumocystis pneumonia diagnosis.
    J Clin Invest. 2025;135:e177241.
    >> Share

  6. SETIABUDIAWAN TP, Hill PC, DiNardo AR, van Crevel R, et al
    Insights into protection against Mycobacterium tuberculosis infection: time to officially confirm another phenotype?
    J Clin Invest. 2025;135:e191423.
    >> Share

    March 2025
  7. MACLEAN F, Tsegaye AT, Graham JB, Swarts JL, et al
    Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract.
    J Clin Invest. 2025 Mar 25:e184609. doi: 10.1172/JCI184609.
    >> Share

  8. ALMEIDA CF, Juno JA
    Sensing mycobacteria through unconventional pathways.
    J Clin Invest. 2025;135:e190230.
    >> Share

  9. KIM MK, Suh GA, Cullen GD, Perez Rodriguez S, et al
    Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches.
    J Clin Invest. 2025;135:e187996.
    >> Share

    January 2025
  10. DALLMANN-SAUER M, Fava VM, Malherbe ST, MacDonald CE, et al
    Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli.
    J Clin Invest. 2025 Jan 21:e188016. doi: 10.1172/JCI188016.
    >> Share

    December 2024
  11. SAKAI Y, Asa M, Hirose M, Kusuhara W, et al
    A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant trehalose monomycolate.
    J Clin Invest. 2024;135:e185443.
    >> Share

  12. TORRES VJ
    Interleukin 10 drives Staphylococcus aureus imprinting and vaccine failure in murine models via antibody glycosylation.
    J Clin Invest. 2024;134:e187055.
    >> Share

  13. TSAI CM, Hajam IA, Caldera JR, Chiang AW, et al
    Pathobiont-driven antibody sialylation through IL-10 undermines vaccination.
    J Clin Invest. 2024;134:e179563.
    >> Share

  14. WANG Q, Hu T, Zhang Q, Zhang Y, et al
    Fusobacterium nucleatum promotes colorectal cancer through neogenesis of tumor stem cells.
    J Clin Invest. 2024 Dec 10:e181595. doi: 10.1172/JCI181595.
    >> Share

    November 2024
  15. DAI Y, Edwards VL, Yu Q, Tettelin H, et al
    Neisseria gonorrhoeae induces local secretion of IL-10 at the human cervix to promote colonization.
    J Clin Invest. 2024;135:e183331.
    >> Share

    October 2024
  16. CHAMBERS HF, Fowler VG Jr
    Intertwining clonality and resistance: Staphylococcus aureus in the antibiotic era.
    J Clin Invest. 2024;134:e185824.
    >> Share

    September 2024
  17. SANCHES SANTOS RIZZO ZUTTION M, Parimon T, Bora SA, Yao C, et al
    Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia.
    J Clin Invest. 2024;134:e180986.
    >> Share

  18. MORGAN SJ, Coulter E, Betts HL, Solomon GM, et al
    Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment.
    J Clin Invest. 2024;134:e184171.
    >> Share

  19. STEERE AC, Lemieux JE
    Wider recognition and greater understanding of postinfectious, antibiotic-refractory Lyme arthritis.
    J Clin Invest. 2024;134:e184109.
    >> Share

    August 2024
  20. BATH J, Bjanes E, Goekeri C, Hsiao J, et al
    Mucins protect against Streptococcus pneumoniae virulence by suppressing pneumolysin expression.
    J Clin Invest. 2024 Aug 22:e182769. doi: 10.1172/JCI182769.
    >> Share

  21. AL-AWQATI Q
    The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases.
    J Clin Invest. 2024;134:e184297.
    >> Share

    July 2024
  22. DIRKS J, Fischer J, Klaussner J, Hofmann C, et al
    Disease-specific T cell receptors maintain pathogenic T helper cell responses in postinfectious Lyme arthritis.
    J Clin Invest. 2024;134:e179391.
    >> Share

    June 2024
  23. BOU GHANEM EN
    CHIPing away at immunity: the role of clonal hematopoiesis of indeterminate potential in bacterial pneumonia.
    J Clin Invest. 2024;134:e181064.
    >> Share

    May 2024
  24. DESAI JV, Zarakas MA, Wishart AL, Roschewski M, et al
    BTK drives neutrophil activation for sterilizing antifungal immunity.
    J Clin Invest. 2024;134:e176142.
    >> Share

  25. BISHU S, Kao JY
    A step closer to understanding how a diet high in simple carbohydrates may cause dysbiosis.
    J Clin Invest. 2024;134:e180001.
    >> Share

    April 2024
  26. QUIN C, DeJong EN, Cook EK, Luo YZ, et al
    Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function.
    J Clin Invest. 2024;134:e171002.
    >> Share

    March 2024
  27. HECHT AL, Harling LC, Friedman ES, Tanes C, et al
    Dietary carbohydrates regulate intestinal colonization and dissemination of Klebsiella pneumoniae.
    J Clin Invest. 2024;134:e174726.
    >> Share

  28. PEEL JN, Yang R, Le Voyer T, Gervais A, et al
    Neutralizing IFN-gamma autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.
    J Clin Invest. 2024;134:e178263.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016